520 results on '"Jensen-Jarolim E"'
Search Results
2. Langzeiteffekte bei gezielter Mikronährstoff-Supplementierung mit der holo-BLG-Lutschtablette bei Patienten mit Hausstaubmilben-induzierter allergischer Rhinokonjunktivitis
3. Gezielte Mikronährstoff-Supplementierung in Patientinnen mit Pollenallergie: eine doppelblinde, Placebo-kontrollierte Pilotstudie
4. Editorial: Warum Urbanisierung zur Allergieepidemie beiträgt und warum Landluft (meist) gesünder ist
5. Vom Ursprung zum Kühlregal: Betrachtung über den Zusammenhang von Milchprozessierung und Kuhmilchallergie
6. AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)
7. Cetirizine inhibits gender-specific blood cell dynamics upon allergen contact in allergic rhinitis
8. Von Hygienehypothese und Mikrobiom zu neuen Konzepten
9. Salivary cortisol responses to acute stress vary between allergic and healthy individuals: the role of plasma oxytocin, emotion regulation strategies, reported stress and anxiety
10. 83. Edible insects in food and feed – far from being well characterized – step 1: a look at allergenicity and ethical aspects
11. Anti-IgE Autoantibodies Hide Specific IgE and Are Mistaken for Specific IgG
12. Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal
13. Deviations of the immune cell lanscape between healthy liver and hepatocellular carcinoma
14. Clinical reactivity of celery cultivars in allergic patients: Role of Api g 1
15. Molecular allergen profiling in horses by microarray reveals Fag e 2 from buckwheat as a frequent sensitizer
16. Preclinical In Vitro and In Vivo Evaluation of [18F]FE@SUPPY for Cancer PET Imaging: Limitations of a Xenograft Model for Colorectal Cancer
17. Allergy diagnosis from symptoms to molecules, or from molecules to symptoms: a comparative clinical study
18. AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer
19. Spontaneous food allergy in Was−/− mice occurs independent of FcεRI‐mediated mast cell activation
20. AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer
21. Comparing immediate‐type food allergy in humans and companion animals—revealing unmet needs
22. Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey
23. Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers
24. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper
25. Editorial
26. AllergoOncology - the impact of allergy in oncology: EAACI position paper
27. Debates in allergy medicine: Molecular allergy diagnosis with ISAC will replace screenings by skin prick test in the future
28. Anwendung von Biologika bei allergischen und Typ-2- entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie – ein Positionspapier von AeDA, DGAKI, GPA, ÖGAI, LGAI, ÖGP, ARIA und EAACI
29. 32nd International Austrian Winter Symposium: Zell am See, the Netherlands. 20-23 January 2016
30. Structural similarities of human and mammalian lipocalins, and their function in innate immunity and allergy
31. Allergens in veterinary medicine
32. Structural similarities of human and mammalian lipocalins, and their function in innate immunity and allergy
33. Allergens in veterinary medicine
34. Epicutaneously applied Der p 2 induces a strong TH2-biased antibody response in C57BL/6 mice, independent of functional TLR4
35. Epicutaneously applied D er p 2 induces a strongT H2‐biased antibody response in C 57 BL /6 mice, independent of functional TLR 4
36. IgE‐based immunotherapy of cancer: challenges and chances
37. Sequential IgE-epitopes of ovomucoid exposed by glutathione are relevant in persistent egg allergy
38. IgE-based immunotherapy of cancer: challenges and chances
39. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B<
40. Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic [Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie]
41. AllergoOncology: microbiota in allergy and cancer - an EAACI position paper
42. Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties
43. An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential
44. 464 Multigene Signature Approach to Assess the Role of AID/APOBEC Family Members During the Epithelial-to-mesenchymal Transition Program
45. 440 Understanding the Potential Role of Sphingolipid Machinery Within the Epithelial to Mesenchymal Transition Process Using a Multigene-signature-based Expression Profiling Approach
46. Monitoring neutrophils and platelets during casein-induced anaphylaxis in an experimental BALB/c mouse model
47. Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?
48. Anti-acid medication as a risk factor for food allergy
49. Antacids and dietary supplements with an influence on the gastric pH increase the risk for food sensitization
50. Suppression of gastric acid increases the risk of developing Immunoglobulin E‐mediated drug hypersensitivity: human diclofenac sensitization and a murine sensitization model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.